New CER tools grant payers the evidence they need to control drug costs
Dave Nellesen
Advertisement
Articles by Dave Nellesen
Advertisement
Latest Updated Articles
The Fruits of Comparative EffectivenessPublished: November 18th 2010 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
The Cost of Fixing Pharma
5
